NO20005835L - Use of tricyclic antidepressants for local analgesia - Google Patents

Use of tricyclic antidepressants for local analgesia

Info

Publication number
NO20005835L
NO20005835L NO20005835A NO20005835A NO20005835L NO 20005835 L NO20005835 L NO 20005835L NO 20005835 A NO20005835 A NO 20005835A NO 20005835 A NO20005835 A NO 20005835A NO 20005835 L NO20005835 L NO 20005835L
Authority
NO
Norway
Prior art keywords
tricyclic antidepressants
local analgesia
analgesia
local
antidepressants
Prior art date
Application number
NO20005835A
Other languages
Norwegian (no)
Other versions
NO20005835D0 (en
Inventor
Jana Sawynok
Mike Esser
Allison Reid
Original Assignee
Univ Dalhousie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dalhousie filed Critical Univ Dalhousie
Publication of NO20005835D0 publication Critical patent/NO20005835D0/en
Publication of NO20005835L publication Critical patent/NO20005835L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20005835A 1998-05-19 2000-11-17 Use of tricyclic antidepressants for local analgesia NO20005835L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/081,709 US6211171B1 (en) 1998-05-19 1998-05-19 Use of antidepressants for local analgesia
PCT/CA1999/000449 WO1999059598A1 (en) 1998-05-19 1999-05-19 Use of tricyclic antidepressants for local analgesia

Publications (2)

Publication Number Publication Date
NO20005835D0 NO20005835D0 (en) 2000-11-17
NO20005835L true NO20005835L (en) 2001-01-18

Family

ID=22165886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005835A NO20005835L (en) 1998-05-19 2000-11-17 Use of tricyclic antidepressants for local analgesia

Country Status (12)

Country Link
US (1) US6211171B1 (en)
EP (1) EP1094818A1 (en)
JP (1) JP2002515438A (en)
KR (1) KR20010071301A (en)
CN (1) CN1308530A (en)
AU (1) AU3807799A (en)
BR (1) BR9911046A (en)
CA (1) CA2333310A1 (en)
NO (1) NO20005835L (en)
NZ (1) NZ508991A (en)
TR (1) TR200003438T2 (en)
WO (1) WO1999059598A1 (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6572880B2 (en) * 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
WO1999059593A1 (en) * 1998-05-21 1999-11-25 Eli Lilly And Company Combination therapy for treatment of depression
AU3422800A (en) * 1999-02-18 2000-09-04 Novartis Ag Use of 5-ht3 receptor antagonists
GB9904163D0 (en) * 1999-02-23 1999-04-14 Bioglan Lab Ltd Pharmaceutical compositions
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
GB9930077D0 (en) * 1999-12-20 2000-02-09 Glaxo Group Ltd Medicaments
US7074961B2 (en) 2000-09-26 2006-07-11 The Brigham And Women's Hospital, Inc. Antidepressants and their analogues as long-acting local anesthetics and analgesics
WO2002026020A2 (en) * 2000-09-26 2002-04-04 The Brigham And Women's Hospital, Inc. Tricyclic antidepressants and their analogues as long-acting local anesthetics and analgesics
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
US6906046B2 (en) 2000-12-22 2005-06-14 Celltech R & D Inc. Pharmaceutical uses and synthesis of benzobicyclooctanes
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
HRP20040102A2 (en) 2001-07-09 2004-10-31 Combinatorx Combinations for the treatment of inflammatory disorders
US6638981B2 (en) * 2001-08-17 2003-10-28 Epicept Corporation Topical compositions and methods for treating pain
US20030082225A1 (en) * 2001-10-19 2003-05-01 Mason Paul Arthur Sterile, breathable patch for treating wound pain
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
MXPA05005609A (en) * 2002-11-26 2005-07-26 Alexza Pharmaceuticals Inc Treatment of headache with antipsychotics delivered by inhalation.
JP2006514934A (en) * 2002-11-26 2006-05-18 アレックザ ファーマシューティカルズ， インコーポレイテッド Use of loxapine or amoxapine for the manufacture of drugs for the treatment of pain
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
MXPA05007381A (en) * 2003-01-13 2006-02-10 Dynogen Pharmaceuticals Inc Method of treating functional bowel disorders.
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
EP1613324A2 (en) * 2003-04-14 2006-01-11 Pain Therapeutics, Inc. Methods for the treatment of pain comprising opioid antagonists
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
US20050209319A1 (en) * 2004-03-18 2005-09-22 Xenoport, Inc. Treatment of local pain
US7585627B2 (en) * 2004-05-21 2009-09-08 Duke University Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1781360A1 (en) 2004-08-12 2007-05-09 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20060039866A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders
EP1827450A4 (en) * 2004-11-17 2009-04-22 Cypress Bioscience Inc Methods for reducing the side effects associated with mirtazapine treatment
WO2006105117A2 (en) * 2005-03-28 2006-10-05 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
US20070270413A1 (en) * 2006-05-22 2007-11-22 N.V. Organon Mirtazapine for the treatment of neuropathic pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
US7960436B2 (en) 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
US7763603B2 (en) * 2006-08-10 2010-07-27 Tyeryar Kimberly R Manipulation of brain CDP-diacylglycerol and uses thereof
US9593360B2 (en) * 2006-08-10 2017-03-14 Ashiwel S Undieh Measurement of brain CDP-diacylglycerol synthase 1 enzyme and uses thereof
SG174095A1 (en) * 2006-08-23 2011-09-29 Valeant Pharmaceuticals Int Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
CN101578259A (en) * 2006-11-28 2009-11-11 威朗国际制药公司 1,4 diamino bicyclic retigabine analogues as potassium channel modulators
WO2008112661A2 (en) 2007-03-09 2008-09-18 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
EP2167096A4 (en) * 2007-06-13 2010-07-14 Cypress Bioscience Inc Improving the tolerability of mirtazapine and a second active by using them in combination
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
CA2716080C (en) 2008-02-20 2016-12-13 Targia Pharmaceuticals Cns pharmaceutical compositions and methods of use
CN101966151B (en) * 2010-09-06 2011-11-09 海南美大制药有限公司 Trimipramine maleate liposome solid preparation
EP2629615B1 (en) 2010-10-22 2018-10-10 Duke University Slow-release formulations of 5-hydroxytryptophan as an adjunct to pro-serotonergic therapies
US20130217673A1 (en) * 2012-02-22 2013-08-22 Warsaw Orthopedic, Inc Mixed monoamine reuptake inhibitor in a biodegradable polymer carrier
ES2961655T3 (en) 2013-01-18 2024-03-13 Kemphys Ltd Medication for treatment of neuropathic disease
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
FR3065371B1 (en) * 2017-04-25 2021-05-21 Laboratoires Mayoly Spindler TOPICAL PHARMACEUTICAL COMPOSITION INCLUDING AT LEAST AMITRIPTYLINE FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAIN
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
TWI886158B (en) 2019-10-10 2025-06-11 加拿大商再諾製藥公司 Solid state crystalline forms of a selective potassium channel modulator
MX2022005490A (en) 2019-11-08 2022-08-10 Xenon Pharmaceuticals Inc Methods of treating depressive disorders.
US11957675B2 (en) 2021-02-09 2024-04-16 Xenon Pharmaceuticals Inc. Methods and uses for treating anhedonia

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3491188A (en) 1967-10-02 1970-01-20 Geigy Chem Corp Pharmaceutical compositions and methods for the treatment of pain with combinations of thioridazine and imipramine,desipramine or pharmaceutically acceptable acid addition salts thereof
US4594358A (en) 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
US5446070A (en) * 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
EP0489108B1 (en) 1989-08-21 1996-03-13 Beth Israel Hospital Association Use of spiperone derivatives for immunosuppression
DK0431663T3 (en) 1989-12-06 1994-03-07 Akzo Nobel Nv Stabilizing solutions of psychotropic agents
US5589511A (en) 1990-08-13 1996-12-31 Sepracor Inc. Method for treating migraine headaches using optically pure S(+) fluoxetine
CA2104873C (en) 1991-02-26 2000-05-23 James N. Campbell Compositions and methods of treatment of sympathetically maintained pain
CA2115792C (en) 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
US6197830B1 (en) 1995-09-22 2001-03-06 Bruce M. Frome Method for achieving relief from sympathetically mediated pain
EP0942751B1 (en) * 1996-07-05 2002-09-25 The WWK Trust Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter

Also Published As

Publication number Publication date
WO1999059598A1 (en) 1999-11-25
NO20005835D0 (en) 2000-11-17
BR9911046A (en) 2001-04-24
US6211171B1 (en) 2001-04-03
CN1308530A (en) 2001-08-15
JP2002515438A (en) 2002-05-28
AU3807799A (en) 1999-12-06
EP1094818A1 (en) 2001-05-02
NZ508991A (en) 2003-09-26
CA2333310A1 (en) 1999-11-25
TR200003438T2 (en) 2001-03-21
KR20010071301A (en) 2001-07-28

Similar Documents

Publication Publication Date Title
NO20005835L (en) Use of tricyclic antidepressants for local analgesia
FI981132L (en) Preventing unauthorized use of the service
DE69818794D1 (en) Improved endocapsular tension ring
DK1112106T3 (en) Serotonergic 5HT2 agonists for the treatment of glaucoma
EE200000640A (en) New use
EE200200704A (en) New compounds, process for their preparation and their use
EE200200470A (en) New compounds, process for their preparation and their use
ID30132A (en) TRICYCLIC PIRAZOL DERIVES
ID30393A (en) TIENOPIRIMIDINA COMPOUNDS, MAKING AND USE OF IT
AR027938A1 (en) URACILO COMPOUNDS AND USE OF THE SAME
EE200200033A (en) New compounds
ID26774A (en) BENZIMIDAZOL COMPOUNDS, MAKING AND USE AS A PHARMACY COMPOSITION
NO991822L (en) Substituted tricyclic compounds
ID29339A (en) INTRODUCTION TO MEDICINE, SPECIALLY FOR ANDROGEN INTRODUCTION
NO993917D0 (en) Removable locking mechanism
NO991823L (en) Substituted tricyclic compounds
MXPA01011760A (en) NEW DIFENILETILENE COMPOUNDS.
AR028248A1 (en) NEW COMPOUNDS 2,3,4,5-TETRAHIDRO-1H- (1,4) DIAZEPINO (1,7-A) INDOL
AR028607A1 (en) DERIVATIVES OF 1,4-DIAZEPAN-2,5-DIONA
FI990937A0 (en) The line of subscriber
IT1308639B1 (en) FLUORINATED TRIAZINIC COMPOUNDS.
IS6141A (en) New compounds
ID26780A (en) COMPOUNDS, TIENOPIRIDINA, THEIR RESULTS AND USE
EE200100156A (en) New composition
NO20015397L (en) 1,5-Benzodiazepine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application